Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26316311 | 0.93 | MAPT (0.34) | MAPTALDH1A1POLBKDM4ENPSR1 | |
| SCHEMBL24256986 | 0.92 | ALOX5 (0.39) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL26316083 | 0.91 | ALDH1A1 (0.36) | MAPTALDH1A1POLBKDM4ENPSR1 | |
| SCHEMBL25802580 | 0.88 | ALOX5 (0.39) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL26313051 | 0.86 | MAPT (0.37) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL24255869 | 0.86 | MAPT (0.40) | MAPTALDH1A1POLBKDM4ENPSR1 | |
| SCHEMBL24256093 | 0.85 | MAPT (0.36) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL26151218 | 0.84 | CDC14B (0.38) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL25835977 | 0.84 | ALOX5 (0.43) | MAPTALOX5ALDH1A1POLBKDM4E | |
| SCHEMBL26043348 | 0.83 | ALOX5 (0.41) | MAPTALOX5ALDH1A1POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | MAPT 376/4885ALOX5 768/4885ALDH1A1 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.